FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013304524> ?p ?o ?g. }

• W2013304524 endingPage "223" @default.
• W2013304524 startingPage "217" @default.
• W2013304524 abstract "Abstract In order to evaluate the efficacy of ursodeoxycholic acid (UDCA) in the treatment of Chinese patients with primary biliary cirrhosis, a short-term, randomized, double-blind controlled, cross-over study was done with long-term follow up. In the first part of the study, 12 patients were randomly chosen to receive either UDCA 600 mg/day for 3 months followed by a placebo for 3 months or a placebo for 3 months followed by UDCA for 3 months. The clinical symptoms of pruritus improved when the patients were receiving UDCA but became worse when receiving a placebo. Mean serum levels of alkaline phosphatase (ALPase), γ-glutamyl transferase (γ-GT), total bilirubin, cholesterol, alanine aminotransferase (ALT) and aspartate aminotransferase all decreased below the baseline values when receiving UDCA treatment and all increased above the baseline values when receiving the placebo. The difference was statistically significant. In the second part of the study, 19 patients received long-term UDCA treatment (mean 20 months). The clinical symptoms of pruritus improved in 90% of the pruritic patients. Serum levels of ALPase, γ-GT and ALT fell significantly from the pretreatment values 6, 12 and from the mean 20 months after UDCA treatment. Serum levels of total bilirubin fell significantly 6 and 12 months after UDCA treatment but did not reach statistical significance at the last follow up. No patient lost antimitochondrial antibody and elevated immunoglobulin levels did not improve significantly, but the Mayo clinical risk score improved significantly after long-term UDCA treatment. Treatment failure was noted in three patients: two patients in the histologic stage IV with clinical overt jaundice died of complications 4 and 5 months after UDCA treatment, respectively; another patient underwent a liver transplantation 1 year after the UDCA treatment due to progressive jaundice. No severe adverse reaction was noted during UDCA treatment, only one patient suffered from a mild allergic reaction. In conclusion, UDCA is safe and effective in the treatment of Chinese PBC patients in stages I—III." @default.
• W2013304524 created "2016-06-24" @default.
• W2013304524 creator A5000983980 @default.
• W2013304524 creator A5022336677 @default.
• W2013304524 creator A5031585842 @default.
• W2013304524 creator A5043805308 @default.
• W2013304524 creator A5047035633 @default.
• W2013304524 creator A5047674805 @default.
• W2013304524 date "1993-06-01" @default.
• W2013304524 modified "2023-10-18" @default.
• W2013304524 title "Ursodeoxycholic acid in the treatment of primary biliary cirrhosis: A short-term, randomized, double-blind controlled, cross-over study with long-term follow up" @default.
• W2013304524 cites W136997036 @default.
• W2013304524 cites W1608626641 @default.
• W2013304524 cites W1753515503 @default.
• W2013304524 cites W1965984516 @default.
• W2013304524 cites W1975517603 @default.
• W2013304524 cites W1975579398 @default.
• W2013304524 cites W1998442274 @default.
• W2013304524 cites W2005232550 @default.
• W2013304524 cites W2013605037 @default.
• W2013304524 cites W2013803788 @default.
• W2013304524 cites W2017287083 @default.
• W2013304524 cites W2036433609 @default.
• W2013304524 cites W2040375465 @default.
• W2013304524 cites W2047318335 @default.
• W2013304524 cites W2061370662 @default.
• W2013304524 cites W2071435565 @default.
• W2013304524 cites W2093113484 @default.
• W2013304524 cites W2094683980 @default.
• W2013304524 cites W2100345391 @default.
• W2013304524 cites W2102061769 @default.
• W2013304524 cites W2121159152 @default.
• W2013304524 cites W2139224962 @default.
• W2013304524 cites W2141861294 @default.
• W2013304524 cites W2316970164 @default.
• W2013304524 cites W2338724594 @default.
• W2013304524 cites W2338915176 @default.
• W2013304524 cites W2393732040 @default.
• W2013304524 cites W2801873603 @default.
• W2013304524 cites W4254615440 @default.
• W2013304524 cites W51141202 @default.
• W2013304524 doi "https://doi.org/10.1111/j.1440-1746.1993.tb01189.x" @default.
• W2013304524 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8100153" @default.
• W2013304524 hasPublicationYear "1993" @default.
• W2013304524 type Work @default.
• W2013304524 sameAs 2013304524 @default.
• W2013304524 citedByCount "23" @default.
• W2013304524 countsByYear W20133045242012 @default.
• W2013304524 countsByYear W20133045242014 @default.
• W2013304524 countsByYear W20133045242015 @default.
• W2013304524 countsByYear W20133045242017 @default.
• W2013304524 countsByYear W20133045242022 @default.
• W2013304524 crossrefType "journal-article" @default.
• W2013304524 hasAuthorship W2013304524A5000983980 @default.
• W2013304524 hasAuthorship W2013304524A5022336677 @default.
• W2013304524 hasAuthorship W2013304524A5031585842 @default.
• W2013304524 hasAuthorship W2013304524A5043805308 @default.
• W2013304524 hasAuthorship W2013304524A5047035633 @default.
• W2013304524 hasAuthorship W2013304524A5047674805 @default.
• W2013304524 hasConcept C126322002 @default.
• W2013304524 hasConcept C141071460 @default.
• W2013304524 hasConcept C142724271 @default.
• W2013304524 hasConcept C160160445 @default.
• W2013304524 hasConcept C168563851 @default.
• W2013304524 hasConcept C181199279 @default.
• W2013304524 hasConcept C185592680 @default.
• W2013304524 hasConcept C204787440 @default.
• W2013304524 hasConcept C27081682 @default.
• W2013304524 hasConcept C2777214474 @default.
• W2013304524 hasConcept C2777513400 @default.
• W2013304524 hasConcept C2779399885 @default.
• W2013304524 hasConcept C2780366471 @default.
• W2013304524 hasConcept C2780965833 @default.
• W2013304524 hasConcept C535046627 @default.
• W2013304524 hasConcept C55493867 @default.
• W2013304524 hasConcept C65409693 @default.
• W2013304524 hasConcept C71924100 @default.
• W2013304524 hasConcept C90924648 @default.
• W2013304524 hasConceptScore W2013304524C126322002 @default.
• W2013304524 hasConceptScore W2013304524C141071460 @default.
• W2013304524 hasConceptScore W2013304524C142724271 @default.
• W2013304524 hasConceptScore W2013304524C160160445 @default.
• W2013304524 hasConceptScore W2013304524C168563851 @default.
• W2013304524 hasConceptScore W2013304524C181199279 @default.
• W2013304524 hasConceptScore W2013304524C185592680 @default.
• W2013304524 hasConceptScore W2013304524C204787440 @default.
• W2013304524 hasConceptScore W2013304524C27081682 @default.
• W2013304524 hasConceptScore W2013304524C2777214474 @default.
• W2013304524 hasConceptScore W2013304524C2777513400 @default.
• W2013304524 hasConceptScore W2013304524C2779399885 @default.
• W2013304524 hasConceptScore W2013304524C2780366471 @default.
• W2013304524 hasConceptScore W2013304524C2780965833 @default.
• W2013304524 hasConceptScore W2013304524C535046627 @default.
• W2013304524 hasConceptScore W2013304524C55493867 @default.
• W2013304524 hasConceptScore W2013304524C65409693 @default.
• W2013304524 hasConceptScore W2013304524C71924100 @default.
• W2013304524 hasConceptScore W2013304524C90924648 @default.
• W2013304524 hasIssue "3" @default.

• next